XLV vs PPH
YTDYear to date
XLV wins+3.7 pts
Past year
PPH wins+0.4 pts
Fee
XLV winslower fee
Yield
PPH wins+0.4 pts
AUM
XLV46.5× more
2–2level
XLV and PPH · year-to-date · as of Nov 8, 2026 · AUM not scored
PPH vs XLV
YTD$118.83 · −0.2% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareXLV+ S&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return−0.2%+8.8%+5.7%+17.2%+29.4%+67.2%+74.2%+372.3%
Peer average+0.8%+5.8%+2.9%+20.5%+29.5%+75.3%+27.5%—
S&P 500 · VOO+0.3%−5.0%−4.6%+8.7%+9.8%+80.8%+71.8%+793.2%
VanEck PPH and XLV · total return, dividends in · as of Nov 8, 2026
PPH’s Holdings
TodayLLYEli Lilly &22.4%MRK12.4%NVO5.5%MCK5.0%PFE4.9%TEVA4.6%BMY4.5%COR4.4%GSK4.3%AZN3.8%NVS3.8%ABBV3.7%SNY3.5%HLN3.4%JNJ3.3%TAK2.9%ZTS2.7%VTRS1.5%JAZZ1.2%ELANAXSM4 more
LLYEli Lilly &22.4%MRK12.4%NVO5.5%MCK5.0%PFE4.9%TEVA4.6%BMY4.5%COR4.4%GSK4.3%AZN3.8%NVS3.8%ABBV14 more
Drug Manufacturers - GeneralDrug Manufacturers - SpecialtyMedical - DistributionBiotechnologyMedical - Pharmaceuticals
VanEck PPH · 26 holdings · tile size = share of the fund · as of Nov 6, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.9% | +20.9% | $49.9B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.8% | +19.8% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +25.0% | +25.0% | $10.0B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +20.0% | +20.0% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +17.0% | +17.0% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.5% | −7.0% | −7.0% | $4.0B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +19.9% | +19.9% | $4.0B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +56.9% | +56.9% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.8% | +26.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.4% | +24.4% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +23.1% | +23.1% | $1.3B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +32.4% | +32.4% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +20.6% | +20.6% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.2% | +17.2% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +22.2% | +22.2% | $584M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +33.9% | +33.9% | $524M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 8, 2026
PPH Payouts by Year
13YLatest payout, Oct 2026
$0.36
a share · every quarter
1.8% yield
1.8% yield
13 years added up
$17.62 a share
$17.62 a share
VanEck PPH · per-share distributions by ex-date · 2014–2026
PPH’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −0.1% | +20.9% | +29.0% | $49.9B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | 0.0% | +19.8% | +27.4% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | +2.6% | +25.0% | +40.0% | $10.0B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −0.2% | +20.0% | +27.9% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.3% | +0.1% | +17.0% | +25.1% | $4.6B | |
| 6 | PPH | VanEck Pharmaceutical ETFThis fund | 0.36% | 1.8% | −0.2% | +17.2% | +29.4% | $1.1B |
#18 of 33 this year · #14 cheapest of 39 · sorted by assetsOpen the Sectors table →
PPH and its peer group · total return · as of Nov 8, 2026
Cards for This View
PPH’s Top 10 Holdings
Today71.8%of PPH sits in these 10
VanEck PPH · weight in the fund · as of Nov 6, 2026
PPH’s Holdings
TodayLLYEli Lilly &22.4%MRK12.4%NVO5.5%MCK5.0%PFE4.9%TEVA4.6%BMY4.5%COR4.4%GSK4.3%AZN3.8%NVS3.8%ABBV3.7%SNY3.5%HLN3.4%JNJ3.3%TAK2.9%ZTS2.7%VTRS1.5%JAZZ1.2%ELANAXSM4 more
LLYEli Lilly &22.4%MRK12.4%NVO5.5%MCK5.0%PFE4.9%TEVA4.6%BMY4.5%COR4.4%GSK4.3%AZN3.8%NVS3.8%ABBV14 more
Drug Manufacturers - GeneralDrug Manufacturers - SpecialtyMedical - DistributionBiotechnologyMedical - Pharmaceuticals
VanEck PPH · 26 holdings · tile size = share of the fund · as of Nov 6, 2026
PPH vs Peer Average
YTDPPHAvsBPeer average
1D−0.2%+0.8%
1M+8.8%+5.8%
3M+5.7%+2.9%
YTD+17.2%+20.5%
1Y+29.4%+29.5%
3Y+67.2%+75.3%
5Y+74.2%+27.5%
3–4Peer average wins
38 Health care peers · each row scaled to its leader